Ophthalmology
-
Randomized Controlled Trial Multicenter Study Clinical Trial
Phase II results of an intraocular steroid delivery system for cataract surgery.
To evaluate the safety and efficacy of an intraocular biodegradable polymer dexamethasone drug delivery system (DEX DDS) in treating postoperative inflammation after cataract surgery. ⋯ The DEX DDS was safe and effective in suppressing postoperative inflammation after uncomplicated cataract surgery. Additional topical anti-inflammatory drops were not needed for most patients.